Try our Advanced Search for more refined results
May 10, 2017
Track this case
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Coherus Biosciences Inc. has told a Delaware federal court that its biosimilar application doesn’t infringe an Amgen Inc. patent covering anti-infection drug Neulasta and that Amgen’s infringement suit should be thrown out.
Already a subscriber? Click here to login